Table 2 Serum Levels of laboratory markers.

From: CEA but not CA19-9 is an independent prognostic factor in patients undergoing resection of cholangiocarcinoma

 

CCA patients median [range], number of analyzed patients

PSC patients median [range], number of analyzed patients

Healthy controls median [range], number of analyzed patients

CEA [µg/l]

2.95 [0.71–110.4], n = 92

1.15 [0.2–5.1], n = 20

1.25 [0.3–6.3], n = 50

CA 19–9 [U/ml]

78.4 [0.5–38092], n = 99

15.95 [2.3–78.4], n = 24

5.4 [0–44.1], n = 50

AFP [ng/ml]

4 [1–177.8], n = 49

1.95 [1–8.7], n = 20

—

WBC [cells/nl]

7.95 [2.9–21.8], n = 190

6.8 [3.3–12.4], n = 23

—

CRP [mg/l]

14.95 [0–230], n = 180

6.4 [0.6–127], n = 20

—

AST [U/l]

45 [15–1587], n = 189

67 [16–108], n = 22

28 [20–78], n = 50

ALT [U/l]

46.5 [10–1097], n = 136

75.5 [22–224], n = 24

20 [5–82], n = 50

GGT [U/l]

293.5 [13–2015], n = 184

265 [18–1223], n = 24

17 [8–120], n = 50

ALP [U/l]

215 [45–1655], n = 184

248 [81–694], n = 24

65 [36–102], n = 50

Bilirubin [mg/dl]

0.9 [0.2–21.49], n = 189

0.89 [0.36–11.07], n = 22

0.41 [0.1–1.46], n = 50

Creatinine [mg/dl]

0.8 [0.4–1.9], n = 190

0.78 [0.3–2.42], n = 23

—

Sodium [mmol/l]

140 [121–146], n = 189

139 [136–144], n = 23

—

Potassium [mmol/l]

4.3 [2.9–7], n = 189

4.25 [3.6–5.3], n = 22

—

Calcium [mmol/l]

2.3 [1.78–5.43], n = 182

2.35 [2.09–2.52], n = 21

—

Haemoglobin [g/l]

12.55 [7.8–19.9], n = 190

14.4 [8.3–16.5], n = 23

—

Platelets [cells/nl]

276.5 [9–931], n = 190

261 [118–417], n = 23

—

  1. WBC: white blood cell count, CRP: C-reactive protein, AST: aspartate transaminase, ALT: alanine transaminase, GGT: Îł-Glutamyl transpeptidase, ALP: alkaline phosphatase, CEA: carcinoembryonic antigen, CA 19-9: carbohydrate-Antigen 19-9, AFP: Alpha-fetoprotein.
Back to article page